Inocucor adds Ben Belldegrun to its Board along with final close of Series B funding round at $15.9m

– USA, CO – Inocucor Corporation, a developer and producer of biological crop inputs for high-value produce and row crops, announced the final close of its Series B funding round at $15.9 million with participation by existing investors Cycle Capital Management (Montreal), Desjardins Innovatech (Montreal), TPG ART (San Francisco), and Pontifax AgTech (Los Angeles).…

Histogenics appoints Sue Washer to its Board of Directors

– USA, MA – Histogenics Corporation (Nasdaq:HSGX), a leader in the development of restorative cell therapies that may offer rapid-onset pain relief and restored function, today announced the appointment of Susan Washer to its Board of Directors.…